Insmed Incorporated
NASDAQ:INSM
Overview | Financials
 | Company Name | Insmed Incorporated | 
| Symbol | INSM | 
| Currency | USD | 
| Price | 146.68 | 
| Market Cap    |  31,004,485,000 | 
| Dividend Yield    |  0% | 
| 52-week-range | 60.4 - 146.91 | 
| Industry | Biotechnology | 
| Sector | Healthcare | 
| CEO | Mr. William H. Lewis J.D., M.B.A. | 
| Website | https://www.insmed.com | 
An error occurred while fetching data.
About Insmed Incorporated
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of 
 Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD









